Comparison of serum symmetric dimethylarginine, creatinine, and cystatin C in Shiba Inu dogs and other breeds Authors: Yuichi MIYAGAWA, Mayu NAKANO, Mio ISHIZAKA, Akiko MIYAGAWA, Hirosumi MIYAKAWA, Naoyuki TAKEMURA Published: 2026 ABSTRACT AbstractThis study investigated breed-related differences in renal biomarkers in clinically healthy dogs, with a focus on Shiba Inu. Serum symmetric dimethylarginine (SDMA), creatinine, and cystatin C concentrations were measured in 23 Shiba Inu and 36 dogs of other breeds. Serum SDMA concentrations were significantly higher in Shiba Inu compared to other breeds. The median serum SDMA concentration (12.3 vs. 9.5 μg/dL) and reference intervals (8.3–18.4 vs. 4.4–14.6 μg/dL) in Shiba Inu were higher than those in other breeds. Serum creatinine concentrations were also higher in Shiba Inu, whereas no consistent differences were observed in serum cystatin C concentrations when body weight was partially matched between groups. These findings suggest that Shiba Inu may have a tendency toward higher SDMA and creatinine concentrations; therefore, when evaluating renal function in this breed, these biomarkers may need to be interpreted cautiously and in conjunction with other clinical assessments.Keywords: creatinine, cystatin C, serum symmetric dimethylarginine, Shiba Inu, kidney INTRODUCTION Symmetrical dimethylarginine (SDMA) is a metabolite produced by the methylation of arginine in nuclear proteins. It is released from cells into the blood during protein breakdown, with approximately 90% excreted by the kidney [10, 18]. In dogs, it is used as an early diagnostic marker for chronic kidney disease (CKD) because it is believed to detect a decrease in glomerular filtration rate at an early stage [6, 16]. While serum creatinine levels are reported to be influenced by muscle mass, unlike creatinine, SDMA is considered unaffected by muscle mass [7]. However, extrarenal factors affecting SDMA remain insufficiently investigated. Greyhounds exhibit elevated serum SDMA concentration compared to other breeds of similar body size [12, 13]. Furthermore, Greyhound puppies show serum SDMA concentration comparable to that of adult Greyhounds and significantly higher than that of puppies of other breeds [1]. In Birman cats, serum SDMA concentration was significantly higher than in cats of other breeds [14]. These breeds are also known to have higher serum creatinine concentrations than other breeds [3, 12, 13, 15, 17]. While differences in muscle mass have been considered the cause of differences in serum creatinine levels, the factors underlying breed differences in serum SDMA levels remain unclear. Such interbreed differences in serum SDMA concentrations suggest that SDMA may have limited utility for early diagnosis of CKD in certain breeds. In Shiba Inu, as in Greyhounds, a higher serum creatinine concentration has been reported compared to other breeds [9]. In this study, cystatin C, another renal biomarker, showed no significant difference compared to other breeds. We hypothesized that Shiba Inu dogs, like Greyhounds and Birman cats, would exhibit elevated serum SDMA and creatinine concentrations. Because SDMA is also used in the International Renal Interest Society (IRIS) CKD staging classification for CKD diagnosis, investigating extrarenal factors is crucial, as they affect early diagnosis and stage assessment. The objective of this study was to compare renal biomarkers, including SDMA, in clinically healthy Shiba Inu dogs with other breeds. MATERIALS AND METHODS Animals This study employed a cross-sectional retrospective design and included 59 clinically healthy dogs that visited the Veterinary Medical Teaching Hospital at Nippon Veterinary and Life Science University between April 2020 and September 2025. These dogs were either visiting for routine health examinations (n=42) or were referred for investigation of polydipsia and polyuria (n=6), evaluation of crystalluria management (n=5), proteinuria (n=3), hypercalcemia (n=2), and bilirubinuria (n=1). These dogs were determined to be clinically healthy based on history, physical examination, complete blood count, blood gas test, serum biochemistry, urinalysis, and abdominal ultrasound. None of the dogs exhibited renal structural abnormalities, impaired urine concentrating ability (urine specific gravity >1.030), proteinuria, or hypertension suggestive of chronic kidney disease. These dogs that presented with polyuria and polydipsia showed no abnormalities in urine concentrating ability, and their water intake did not exceed 100 mL/kg/day; therefore, they were not considered to have clear clinical signs of polyuria or polydipsia. The dogs that presented for evaluation of crystalluria had no evidence of urolithiasis based on imaging examinations. In the dogs referred for evaluation of proteinuria or hypercalcemia, these findings were not confirmed upon examination at our hospital. The dog presenting with bilirubinuria had a urine dipstick bilirubin level of 1+ and no evidence of liver disease or hemolytic anemia on other examinations. Based on the above screening test results, these 17 dogs were considered healthy. Seventeen dogs referred for suspected disease were also found to be clinically healthy and free of disease after re-evaluation of clinical signs and the clinical tests mentioned above. For the two Shiba Inu with serum creatinine concentrations exceeding the reference range (>1.4 mg/dL), endogenous creatinine clearance was performed to rule out renal dysfunction. The endogenous creatinine clearance procedure was performed as previously reported, with >1.5 mL/min/kg considered indicative of normal renal function [4]. Only dogs with a Body Condition Score (BCS) of 3/5 were included; all others were excluded. Measurement of renal biomarkers Renal biomarker measurements were performed on samples collected during the blood test at the hospital visit. Blood samples were collected from either the jugular vein, radial skin vein, or lateral saphenous vein using a 23G or 25G needle. Immediately after collection, the blood was pipetted into serum separation tubes and centrifuged at 3,000 rpm for 5 min. Serum urea nitrogen, creatinine, and cystatin C concentrations were measured in-house within 30 min of blood collection. Serum SDMA concentration was outsourced to an external testing facility (IDEXX Laboratories, Tokyo, Japan) using serum samples stored frozen at −80°C. Serum levels of urea nitrogen and creatinine were determined enzymatically using an automatic analyzer (7180 Automatic Analyzer; Hitachi High-tech, Tokyo, Japan). Serum levels of cystatin C were measured by a latex agglutination method (Iatro Cystatin C, LSI Mediation, Tokyo, Japan) [8] per manufacturer’s instructions within 30 min of blood collection. This assay, which used a rabbit polyclonal anti-human Cystatin C antibody, was also performed on an automatic analyzer (7180 Automatic Analyzer; Hitachi High-Tech, Tokyo, Japan). Statistical analysis Statistical analysis was performed using the SPSS statistical software package (IBM SPSS Statistics ver.25, IBM Japan, Tokyo, Japan), Microsoft Excel, and Reference Value Advisor v2.1 Add-In (Freeware v2.1: http://www.biostat.envt.fr/reference-value-advisor). Data normality was assessed using the Shapiro–Wilk test. All data were non-normally distributed and presented as median (25th and 75th percentiles). Comparisons between Shiba Inu and other breeds of dogs by sex were performed using the χ2 test, while serum concentrations of urea nitrogen, creatinine, SDMA, and cystatin C were compared using the Mann–Whitney U-test. Correlations between urea nitrogen, creatinine, SDMA, and cystatin C, and age and weight were evaluated for Shiba Inu and other breeds using the Spearman rank correlation coefficient. In accordance with American Society for Veterinary Clinical Pathology (ASVCP) guidelines, breed-specific reference intervals (RI) and 90% confidence intervals (CI) were determined using Reference Value Advisor v2.1 Add-In [5]. Both the Dixon and Tukey tests were used to detect outliers, and outliers were retained unless clear reasons for classifying them as abnormal values were found, following the ASVCP guidelines. P values <0.05 were considered statistically significant. RESULTS This study’s analysis included 23 Shiba Inu dogs and 36 dogs of other breeds, for a total of 59 dogs. The characteristics of the included dogs are shown in Table 1. The breeds other than Shiba Inu included in this study were as follows: Beagle (n=9), Toy Poodle (n=5), Mixed Breed (n=4), Pomeranian (n=3), Golden Retriever (n=2), Chihuahua (n=2), Yorkshire Terrier (n=2), Cavalier King Charles Spaniel (n=1), Shetland Sheepdog (n=1), French Bulldog (n=1), Border Collie (n=1), Maltese (n=1), Medium Poodle (n=1), Miniature Pinscher (n=1), Brussels Griffon (n=1), and Miniature Dachshund (n=1). There were no significant differences between the Shiba Inu and dogs of other breeds in age (P=0.234) or weight (P=0.103), nor in sex (P=0.115). Table 1.Characteristics of Shiba Inu dogs and other breeds of dogsCategoryShiba Inu (n=23)Other breed dogs (n=36)Age (years)6.5 (3.1, 10.5)5.1 (2.9, 8.0)Body Weight (kg)10.0 (8.5, 11.7)5.8 (3.6, 13.2)SexMale intact, n313Male neutered, n913Female intact, n13Female neutered, n107Data were presented as median (25th, 75th percentiles). Characteristics of Shiba Inu dogs and other breeds of dogs Data were presented as median (25th, 75th percentiles). Serum concentrations of creatinine, cystatin C, and SDMA did not follow a normal distribution. No outliers were detected for any variable using the Dixon or Tukey method. Serum SDMA concentrations were significantly higher in Shiba Inu compared to other breeds (P<0.001) (Fig. 1). The median serum SDMA concentration (12.3 vs. 9.5 μg/dL) and RI (8.3–18.4 vs. 4.4–14.6 μg/dL) in Shiba Inu were higher than those in other breeds (Table 2). Five Shiba Inu dogs (15, 15, 15, 17, and 19 μg/dL) and one dog of other breeds (17 μg/dL) exceeded the reference range (0.0–14.0 μg/dL) indicated by the testing company. Serum creatinine, cystatin C levels of these five Shiba Inu dogs were as follows: (1) 18.0 mg/dL, 1.02 mg/dL, 0.36 mg/L (SDMA 15 μg/dL), (2) 18.7, 1.29, 0.34 (SDMA 15 μg/dL), (3) 16.5, 1.06, 0.31 (SDMA 15 μg/dL), (4) 13.4, 1.56, 0.38 (SDMA 17 μg/dL), and (5) 14.9, 1.46, 0.22 (SDMA 19 μg/dL). The urea nitrogen, creatinine, and cystatin C levels of one dog of other breeds (mixed-breed dog, body weight 3.8 kg) were 14.6, 0.74, and 0.19. Serum SDMA concentration in Shiba Inu and other breed dogs. The boxes represent 50% of the serum SDMA levels; lines within the boxes represent the median, and the top and bottom of each box correspond to the 75th and 25th percentiles, respectively. The whiskers (error bars) indicate the 95% confidence interval: *P<0.001. SDMA; symmetric dimethylarginine. Table 2.Laboratory results for Shiba Inu dogs and other breeds of dogsParameterShiba InuOther breed dogsCrearinine (mg/dL)Median1.130.66RI0.63–1.660.46–1.2890% CI for lower limit0.54–0.780.44–0.4990% CI for upper limit1.47–1.791.07–1.52Cystatin C (mg/L)Median0.290.20RI0.17–0.410.11–0.3990% CI for lower limit0.15–0.210.10–0.1390% CI for upper limit0.38–0.440.33–0.47SDMA (mg/dL)Median12.39.5RI8.3–18.44.4–14.690% CI for lower limit7.5–9.83.2–5.790% CI for upper limit15.8–20.613.0–16.2RI; reference intervals, SDMA; symmetric dimethylarginine. Laboratory results for Shiba Inu dogs and other breeds of dogs RI; reference intervals, SDMA; symmetric dimethylarginine. Compared with other breeds, Shiba Inu dogs had significantly higher serum creatinine concentrations (P<0.001), with higher median values (1.13 vs. 0.66 mg/dL) and RI (0.63–1.66 vs. 0.46–1.28 mg/dL) (Fig. 2 and Table 2). Two Shiba Inu dogs (1.46 and 1.56 mg/dL, respectively) exceeded the reference range (0.40–1.45 mg/dL) for the analyzer, while no dogs of other breeds did. These two dogs had higher serum SDMA concentrations (19 and 17 μg/dL), and underwent endogenous creatinine clearance testing, yielding values of 2.4 mL/min/kg and 2.7 mL/min/kg, respectively. Serum creatinine concentration in Shiba Inu and other breed dogs. The boxes represent 50% of the serum creatinine levels; lines within the boxes represent the median, and the top and bottom of each box correspond to the 75th and 25th percentiles, respectively. The whiskers (error bars) indicate the 95% confidence interval: *P<0.001. Compared to other breeds, Shiba Inu dogs had significantly higher serum cystatin C concentrations (P<0.001), with a higher median (0.29 vs. 0.20 mg/L) and slightly higher RI (0.17–0.41 vs. 0.11–0.39 mg/L) (Fig. 3 and Table 2). No Shiba Inu dogs exceeded the reference range (0.00–0.40 mg/L) for the analyzer used, whereas one dog of another breed had a serum cystatin C concentration exceeding the reference range (0.48 mg/L). Serum cystatin C concentration in Shiba Inu and other breed dogs. The boxes represent 50% of the serum cystatin C levels; lines within the boxes represent the median, and the top and bottom of each box correspond to the 75th and 25th percentiles, respectively. The whiskers (error bars) indicate the 95% confidence interval: *P<0.001. Evaluating all dogs, age showed a significant positive correlation with creatinine (r=0.342, P=0.008) and cystatin C (r=0.276, P=0.036), and showed a positive correlation with creatinine (r=0.263, P=0.044). Serum creatinine concentration showed a significant positive correlation with serum cystatin C (r=0.575, P<0.001) and SDMA concentration (r=0.457, P<0.001) (Fig. 4). Serum cystatin C positively correlated with SDMA concentration (r=0.403, P=0.002). The correlation between serum SDMA concentration and age (A), body weight (B), creatinine (C), cystatin C (D) in Shiba Inu (triangle) and other breeds of dogs (circle). SDMA; symmetric dimethylarginine. When evaluating correlations within the Shiba Inu group only, age showed a significant correlation with cystatin C (r=0.456, P=0.029), while body weight did not correlate with any variable. Serum creatinine and serum cystatin C concentrations showed a significant positive correlation (r=0.554, P=0.006), whereas no significant correlations were observed among the other renal biomarkers. In the group of other breeds only, age showed a significant correlation only with creatinine (r=0.447, P=0.006), and body weight showed significant inverse correlations with SDMA (r=−0.407, P=0.014). No significant correlations were observed among renal biomarkers. The median body weight of the Shiba Inu dogs was 10.0 kg (range, 5–18 kg). To match the body weight range with that of the other breeds, we conducted a sub-analysis including only dogs weighing 5.0–15.0 kg. In addition, because serum creatinine was correlated with age, only dogs aged 1–8 years were selected for this sub-analysis. As a sub-analysis, serum creatinine, cystatin C, and SDMA were compared between Shiba Inu and other breeds (Shiba Inu, n=13; other breeds, n=12). Serum creatinine and SDMA concentrations were higher in Shiba Inu than in the other breeds (P<0.05). The median serum creatinine concentration was 1.06 mg/dL (0.99, 1.39) in Shiba Inu and 0.65 mg/dL (0.59, 0.73) in other breed dogs, and the median serum SDMA concentration was 12.0 µg/dL (11.5, 14.0) and 8.0 µg/dL (7.0, 9.0), respectively. There was no significant difference in cystatin C concentrations between the breeds (P=0.127). The median serum cystatin C concentration was 0.28 mg/L (0.22, 0.31) in Shiba Inu and 0.20 mg/L (0.15, 0.26) in other breed dogs. Furthermore, when dogs with serum SDMA concentrations exceeding the reference range (>14 μg/dL) were excluded (Shiba Inu, n=10; other breeds, n=11), serum creatinine and SDMA concentrations remained significantly higher in Shiba Inu (P<0.05). When the correlations between body weight and each biomarker were evaluated within each group, no significant associations were observed for any biomarker (P>0.05). The median serum creatinine concentration was 1.0 mg/dL (0.93, 1.34) in Shiba Inu and 0.65 mg/dL (0.58, 0.68) in other breed dogs, and the median serum SDMA concentration was 11.7 µg/dL (11.0, 12.3) and 8.0 µg/dL (7.0, 9.0), respectively. DISCUSSION In this study, serum SDMA, creatinine, and cystatin C concentrations in Shiba Inu dogs were significantly higher than in other breed groups. Serum SDMA concentration has been reported to be unaffected by body weight and muscle mass. However, significantly higher concentrations have been reported in Greyhounds compared to other breeds of similar body size [12, 13]. In the sub-analysis of cases with a partially matched body weight range in the present study, serum SDMA concentration remained significantly higher in Shiba Inu compared with the other breeds. The RI for SDMA in Greyhounds in the study by Liffman et al. [12] was 6.3–19.9 μg/dL, similar to the RI for Shiba Inu in this study (8.3–18.4 μg/dL). In a study of juvenile Greyhounds [1], serum SDMA concentrations were similarly elevated compared to adults, leading the authors to suggest factors other than renal function were responsible for the high levels. Protein arginine methyltransferase 5 (PRMT5) is a key factor in cancer and stem cell biology. PRMT5 is universally expressed and functions as the primary factor catalyzing symmetric dimethylarginine (SDMA) modification on proteins. Studies in mice have reported its involvement in hematopoiesis and skeletal muscle regeneration [19, 21]. Couto et al. hypothesized that the high hematopoietic capacity and muscle regeneration in the racing dog Greyhound, which has high PRMT5 expression, is the cause of elevated SDMA levels [1]. This study could not clarify the factors causing elevated serum SDMA concentrations in Shiba Inu dogs. Unlike Greyhounds, Shiba Inu are not racing dogs, and it is unclear whether high PRMT5 activity is involved. While there are reports comparing GFR between Greyhounds and other breeds [2], no studies have compared GFR measurements between Shiba Inu and other breeds. Therefore, it is also unclear whether Shiba Inu exhibits lower GFR than other breeds. The reason why serum SDMA concentrations were higher in Shiba Inu than in other breeds could not be clarified in this study. However, the results of this study may suggest that Shiba Inu dogs in this study—5/26 of which had serum SDMA levels exceeding the existing reference ranges and a high RI—may have a tendency toward higher SDMA concentrations than other breeds. Therefore, when suspecting kidney disease, testing may need to include other biomarkers and be evaluated cautiously. In addition to these findings of the sub-analysis, even when within the reference interval, their SDMA concentrations tended to be higher than those of other breeds. Given previous reports of individual variability [11], it may be necessary to note that SDMA levels in Shiba Inu can transiently exceed the reference interval. Serum creatinine concentration has been reported to correlate with body weight in previous studies due to its influence by muscle mass [7], and Shiba Inu have also been reported to have higher serum creatinine concentration than other breeds [9]. However, the study by Iwasa et al. included dogs weighing <15 kg, and the Shiba Inu were the largest breed group among the studied breeds. It is unknown whether Shiba Inu dogs exhibit greater muscle mass than other breeds of similar stature, similar to Greyhounds [3, 13], which have higher muscle mass and elevated serum creatinine levels compared to breeds of the same stature. In this study, although there was no significant difference in weight between Shiba Inus and other breeds, the comparison did not include breeds of similar body size. Therefore, it could not be determined whether the difference in serum creatinine concentration was influenced by body size or muscle mass. This is because the primary objective of this study was to compare serum SDMA concentrations, not to compare serum creatinine concentrations across breeds. In Shiba Inu, serum cystatin C concentration was significantly higher than in other breed groups. Previous studies showed no significant differences in serum cystatin C concentration between breeds [9]. While serum cystatin C concentration has been reported to correlate with body weight [1, 14, 17], it is associated with fat mass rather than muscle mass [20]. When Shiba Inu were compared with other breeds whose body weights were partially matched, no significant differences were observed in serum cystatin C concentrations. In this study, serum cystatin C concentration correlated significantly with age but not with body weight. This study excluded dogs with BCS other than 3/5, indicating emaciation or obesity. However, BCS is a subjective assessment, and dogs with mild obesity were included, which may have influenced the inter-breed differences in serum cystatin C concentration. Although Shiba Inu dogs showed significantly higher serum cystatin C concentrations than other breeds, none of the Shiba Inu dogs exhibited cystatin C levels exceeding the reference range, suggesting minimal implications for clinical utility. This study has several limitations. First, in this study, GFR was not assessed using clearance methods in any of the dogs. While dogs with serum creatinine concentration exceeding the reference range in this study underwent a urinary creatinine clearance test to confirm the absence of renal impairment, dogs with serum SDMA concentrations alone exceeding the reference range did not undergo this clearance test. Therefore, dogs showing elevated serum SDMA concentrations alone may have had renal impairment. However, some dogs that did not undergo clearance testing may have had reduced GFR and CKD, which could have influenced the results of this study. Second, serum SDMA concentration was measured in all dogs via a single blood draw. Since greater intra-individual variability in serum SDMA concentration has been reported compared to serum creatinine [11], it cannot be ruled out that this variability influenced the present results. Nevertheless, since clinical practice often relies on single measurements for evaluation, these findings may serve as one piece of evidence supporting the use of SDMA to assess kidney function in Shiba Inu dogs. In conclusion, serum SDMA, creatinine, and cystatin C concentrations tended to be higher in Shiba Inu dogs compared with dogs of other breeds in this study. These findings suggest that, when evaluating renal function in Shiba Inu, it may be helpful to interpret these biomarkers in conjunction with other diagnostic tests such as urinalysis and imaging studies. Conflicts of Interest The authors declare no conflict of interest. REFERENCES